2012-02-09 08:23:05 - Covidien - Company Intelligence Report - a new company profile report on companiesandmarkets.com

Covidien offers an extensive healthcare product line that spans medical devices, medical supplies and pharmaceuticals. Since 1994, the company has significantly expanded its product portfolio, primarily through key acquisitions, such as Kendall, Mallinkrodt (and its subsidiaries, Nellcor and Puritan Bennett) and US Surgical (including its subsidiary, Valleylab). As of September 2011, Covidien employed approximately 41,300 people in 65 countries worldwide. It had 48 manufacturing facilities in 16 countries and its products were sold in over 140 countries.
Covidien Ltd (formerly Tyco Healthcare) was formed on 29th June 2007 after Tyco International, its former parent company, was separated into three independent, publicly-traded companies. Tyco International transferred the equity of the entities that held all of the assets and liabilities of its healthcare

 

 

business to Covidien and distributed all of its shares of Covidien to its shareholders. The shares of Covidien began trading on the New York and Bermuda stock exchanges on 2nd July 2007.
In 2009, Covidien moved its principal executive office from Bermuda to Dublin, Ireland, and ceased trading its shares on the Bermuda stock exchange. The company´s corporate offices are located in Mansfield, Massachusetts, US.
Since 2008, Covidien has sold several businesses consistent with its strategy to streamline its portfolio and re-allocate resources to faster-growing, higher-margin operations. These have included the sale of its Retail Products, European Incontinence, Speciality Chemicals, Sleep Diagnostics, and Oxygen and Sleep Therapy assets.
Following on from the key acquisitions mentioned above, which included a number of globally-recognised brands, Covidien has targeted its investments at businesses that complement its existing portfolio or enable it to enter adjacent markets, as well as obtain licences to access new technologies. The purchases of Aspect Medical, VNUS Medical Technologies, ev3, Somanetics and Barrx Medical are typical examples of this.
In 2009, Covidien made a number of segment reporting changes to align external reporting with changes to its internal reporting structure. The company combined its Pharmaceutical Products and Imaging Solutions segments into a single operating segment called Pharmaceuticals. In addition, it reclassified the SharpSafety and Clinical Care product lines in the US and Europe from its Medical Devices segment to the Medical Supplies segment. The company also reclassified several hernia mechanical devices from its Endomechanical Instruments product line to its Soft Tissue Repair product line, both within the Medical Devices segment, and made several other less significant transfers between product lines and segments. As a result of these changes, Covidien now manages and operates its business through three segments:
Medical Devices - includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, products used in vascular therapies and other medical products;
Medical Supplies - includes the development, manufacture and sale of nursing care products, medical surgical products, SharpSafety products and original equipment manufacturer (OEM) products; and Pharmaceuticals - includes the development, manufacture and distribution of specialty pharmaceuticals, active pharmaceutical ingredients, contrast products and radiopharmaceuticals.
In the fiscal year (FY) ended September 2011, Covidien reported net income of US$1.87 billion on revenues of US$11.57 billion. Approximately 55% of the company´s net sales are generated in the US and 45% are generated outside of the US. This report primarily focuses on the Medical Devices and Medical Supplies segments of Covidien´s business.
Report Scope
This Medical Device Company Intelligence Report provides a full review of the company´s activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company+Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.